Method of treatment using new leurosine derivatives
US4279916A · kind A · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 1977 |
| Grant date | Jul 21, 1981 |
| Priority date | — |
| Expiry date | Sep 20, 1997 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Multiple myeloma in human patients is treated by administering N-formylleurosine or its sulfate salt.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.